Pattern recognition receptors may be potent new drug targets for immune-mediated diseases

Chronic inflammation caused by activation of the human immune system contributes to a large and rapidly growing list of diseases including some cancers, cardiovascular disease, metabolic disorders, and autoimmune diseases. Significant advances in understanding the role that the cytokine-mediated JAK/STAT signaling network and pattern recognition receptors (PRRs) play in regulating immune responses and their potential as novel targets for developing potent new therapies are presented in a Review article in Journal of Interferon & Cytokine Research (JICR).

Brendan John Jenkins, MIMR-PHI Institute of Medical Research (Clayton, Victoria, Australia), reviews the latest research and highlights key findings that help explain how cross-talk between cell signaling networks mediated by cytokines and PRRs can impact the development of a variety of disease processes. The authors describe the potential therapeutic implications of targeting these critical networks in the article "Transcriptional Regulation of Pattern Recognition Receptors by JAK/STAT Signaling, and the Implications for Disease Pathogenesis."

"Dr. Jenkins provides an important new perspective on the role of pattern recognition receptors in disease pathogenesis," says JICR Co-Editor-in-Chief Thomas A. Hamilton, PhD, Chairman, Department of Immunology, Cleveland Clinic Foundation, Ohio.

The article is available free on the Journal of Interferon & Cytokine Research website until November 15, 2014.

Explore further

A new target for controlling inflammation? Long non-coding RNAs fine-tune the immune system

More information: Jenkins Brendan John. Journal of Interferon & Cytokine Research. October 2014, 34(10): 750-758. DOI: 10.1089/jir.2014.0081.
Citation: Pattern recognition receptors may be potent new drug targets for immune-mediated diseases (2014, October 15) retrieved 21 April 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments